Ophthalmic pterygium: A stem cell disorder with premalignant features

American Journal of Pathology

Volumn 178, Issue 2, 2011, Pages 817-827

  Chui, Jeanie ^a   Coroneo, Minas T ^b,c   Tat, Lien T ^c   Crouch, Roger ^b   Wakefield, Denis ^a   Di Girolamo, Nick ^a  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b PRINCE OF WALES HOSPITAL   (Australia)

^c Ophthalmic Surgeons   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKERATIN 15; CYTOKERATIN 19; IMMUNOGLOBULIN G; PROTEIN P63;

ADULT; ANGIOGENESIS; ARTICLE; BOWMAN MEMBRANE; CELL DAMAGE; CELL HYPERPLASIA; CELL PROLIFERATION; CLINICAL ASSESSMENT; DISSOLUTION; ELASTOSIS; EPITHELIUM BASAL CELL; EPITHELIUM CELL; FEMALE; GOBLET CELL; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; MELANOSIS; PRIORITY JOURNAL; PTERYGIUM; RADIATION EXPOSURE; SQUAMOUS CELL CARCINOMA; STEM CELL DISORDER; ULTRAVIOLET RADIATION;

EID: 79951815085     PISSN: 00029440     EISSN: 15252191     Source Type: Journal    
DOI: 10.1016/j.ajpath.2010.10.037     Document Type: Article

References (78)

1. Duke-Elder S (Ed): Diseases of the Outer Eye Part 1. System of Ophthalmology 8. London: Kimpton, 1965, pp 569-585
2. Di Girolamo N, Chui J, Coroneo MT, Wakefield D: Pathogenesis of pterygia: role of cytokines, growth factors, and matrix metalloproteinases. Prog Retin Eye Res 2004, 23:195-228 (Pubitemid 38496401)
3. Di Girolamo N, McCluskey P, Lloyd A, Coroneo MT, Wakefield D: Expression of MMPs and TIMPs in human pterygia and cultured pterygium epithelial cells. Invest Ophthalmol Vis Sci 2000, 41:671-679 (Pubitemid 30158875)
4. Di Girolamo N, Coroneo MT, Wakefield D: Active matrilysin (MMP-7) in human pterygia: potential role in angiogenesis. Invest Ophthalmol Vis Sci 2001, 42:1963-1968 (Pubitemid 32726025)
5. Di Girolamo N, Kumar RK, Coroneo MT, Wakefield D: UVB-mediated induction of interleukin-6 and -8 in pterygia and cultured human pterygium epithelial cells. Invest Ophthalmol Vis Sci 2002, 43:3430-3437 (Pubitemid 35334350)
6. Di Girolamo N, Coroneo MT, Wakefield D: UVB-elicited induction of MMP-1 expression in human ocular surface epithelial cells is mediated through the ERK1/2 MAPK-dependent pathway. Invest Ophthalmol Vis Sci 2003, 44:4705-4714 (Pubitemid 37315282)
7. Di Girolamo N, Coroneo M, Wakefield D: Epidermal growth factor receptor signaling is partially responsible for the increased matrix metalloproteinase-1 expression in ocular epithelial cells after UVB radiation. Am J Pathol 2005, 167:489-503 (Pubitemid 43026104)
8. Di Girolamo N, Wakefield D, Coroneo MT: UVB-mediated induction of cytokines and growth factors in pterygium epithelial cells involves cell surface receptors and intracellular signaling. Invest Ophthalmol Vis Sci 2006, 47:2430-2437 (Pubitemid 351639824)
9. Chui J, Di Girolamo N, Wakefield D, Coroneo MT: The pathogenesis of pterygium: current concepts and their therapeutic implications. Ocul Surf 2008, 6:24-43 (Pubitemid 351902631)
10. Kobayashi H, Kohshima S: Unique morphology of the human eye. Nature 1997, 387:767-768 (Pubitemid 27270891)
11. Moran DJ, Hollows FC: Pterygium and ultraviolet radiation: a positive correlation. Br J Ophthalmol 1984, 68:343-346 (Pubitemid 15118324)
12. Threlfall TJ, English DR: Sun exposure and pterygium of the eye: a dose-response curve. Am J Ophthalmol 1999, 128:280-287 (Pubitemid 29413222)
13. McCarty CA, Fu CL, Taylor HR: Epidemiology of pterygium in Victoria, Australia. Br J Ophthalmol 2000, 84:289-292 (Pubitemid 30251685)
14. Tan CS, Lim TH, Koh WP, Liew GC, Hoh ST, Tan CC, Au Eong KG: Epidemiology of pterygium on a tropical island in the Riau Archipelago. Eye 2006, 20:908-912 (Pubitemid 44210183)
15. Lim R, Mitchell P, Cumming RG: Cataract associations with pinguecula and pterygium: the Blue Mountains Eye Study. Am J Ophthalmol 1998, 126:717-719 (Pubitemid 28514245)
16. Taylor HR, West SK, Rosenthal FS, Munoz B, Newland HS, Emmett EA: Corneal changes associated with chronic UV irradiation. Arch Ophthalmol 1989, 107:1481-1484 (Pubitemid 19247253)
17. Clear AS, Chirambo MC, Hutt MS: Solar keratosis, pterygium, and squamous cell carcinoma of the conjunctiva in Malawi. Br J Ophthalmol 1979, 63:102-109 (Pubitemid 9083296)
18. Kerkenezov N: A pterygium survey of the far north coast of New South Wales. Trans Ophthalmol Soc Aust 1956, 16:110-119
19. Di Girolamo N: Signalling pathways activated by ultraviolet radiation: role in ocular and cutaneous health. Curr Pharm Des 2010, 16:1358-1375
20. Coroneo MT, Muller-Stolzenburg NW, Ho A: Peripheral light focusing by the anterior eye and the ophthalmohelioses. Ophthalmic Surg 1991, 22:705-711
21. Di Girolamo N, Bosch M, Zamora K, Coroneo MT, Wakefield D, Watson SL: A contact lens-based technique for expansion and transplantation of autologous epithelial progenitors for ocular surface reconstruction. Transplantation 2009, 87:1571-1578
22. Figueira EC, Di Girolamo N, Coroneo MT, Wakefield D: The phenotype of limbal epithelial stem cells. Invest Ophthalmol Vis Sci 2007, 48:144-156 (Pubitemid 47251397)
23. Davanger M, Evensen A: Role of the pericorneal papillary structure in renewal of corneal epithelium. Nature 1971, 229:560-561
24. Goldberg MF, Bron AJ: Limbal palisades of Vogt. Trans Am Ophthalmol Soc 1982, 80:155-171 (Pubitemid 13059259)
25. Shortt AJ, Secker GA, Munro PM, Khaw PT, Tuft SJ, Daniels JT: Characterization of the limbal epithelial stem cell niche: novel imaging techniques permit in vivo observation and targeted biopsy of limbal epithelial stem cells. Stem Cells 2007, 25:1402-1409 (Pubitemid 47106007)
26. Tseng SCG, Chen JJY, Huang AJW, Kruse FE, Maskin SL, Tsai RJF: Classification of conjunctival surgeries for corneal diseases based on stem cell concept. Ophthalmol Clin North Am 1990, 3:595-610
27. Huang AJ, Tseng SC: Corneal epithelial wound healing in the absence of limbal epithelium. Invest Ophthalmol Vis Sci 1991, 32:96-105
28. Mourits MP, Wyrdeman HK, Jurgenliemk-Schulz IM, Bidlot E: Favorable long-term results of primary pterygium removal by bare sclera extirpation followed by a single 90Strontium application. Eur J Ophthalmol 2008, 18:327-331
29. Hirst LW: The treatment of pterygium. Surv Ophthalmol 2003, 48:145-180
30. Ang LP, Chua JL, Tan DT: Current concepts and techniques in pterygium treatment. Curr Opin Ophthalmol 2007, 18:308-313 (Pubitemid 46955297)
31. Sevel D, Sealy R: Pterygia and carcinoma of the conjunctiva. Trans Ophthalmol Soc UK 1969, 88:567-578
32. Hirst LW, Axelsen RA, Schwab I: Pterygium and associated ocular surface squamous neoplasia. Arch Ophthalmol 2009, 127:31-32
33. Perra MT, Colombari R, Maxia C, Zucca I, Piras F, Corbu A, Bravo S, Scarpa A, Sirigu P: Finding of conjunctival melanocytic pigmented lesions within pterygium. Histopathology 2006, 48:387-393
34. Erie JC, Campbell RJ, Liesegang TJ: Conjunctival and corneal intraepithelial and invasive neoplasia. Ophthalmology 1986, 93:176-183 (Pubitemid 16079555)
35. Coroneo MT: Beheading the pterygium. Ophthalmic Surg 1992, 23:691-692
36. Fuchs E: Ueber das Pterygium [Concerning the pterygium]. German. Graefes Arch Ophthalmol 1892, 38:1-89
37. Garner A: The pathology of tumours at the limbus. Eye (Lond) 1989, 3:210-217
38. Kato N, Shimmura S, Kawakita T, Miyashita H, Ogawa Y, Yoshida S, Higa K, Okano H, Tsubota K: Beta-catenin activation and epithelialmesenchymal transition in the pathogenesis of pterygium. Invest Ophthalmol Vis Sci 2007, 48:1511-1517 (Pubitemid 351261333)
39. Perra MT, Maxia C, Zucca I, Piras F, Sirigu P: Immunohistochemical study of human pterygium. Histol Histopathol 2002, 17:139-149 (Pubitemid 34116417)
40. Ribatti D, Nico B, Maxia C, Longo V, Murtas D, Mangieri D, Perra MT, De Giorgis M, Piras F, Crivellato E, Sirigu P: Neovascularization and mast cells with tryptase activity increase simultaneously in human pterygium. J Cell Mol Med 2007, 11:585-589 (Pubitemid 47153468)
41. John-Aryankalayil M, Dushku N, Jaworski CJ, Cox CA, Schultz G, Smith JA, Ramsey KE, Stephan DA, Freedman KA, Reid TW, Carper DA: Microarray and protein analysis of human pterygium. Mol Vis 2006, 12:55-64 (Pubitemid 43137827)
42. Naib-Majani W, Eltohami I, Wernert N, Watts W, Tschesche H, Pleyer U, Breipohl W: Distribution of extracellular matrix proteins in pterygia: an immunohistochemical study. Graefes Arch Clin Exp Ophthalmol 2004, 242:332-338 (Pubitemid 38647608)
43. Vojniković B, Njirić S, Zamolo G, Toth I, Apanjol J, Coklo M: Histopathology of the pterygium in population on Croatian Island Rab. Coll Antropol 2007, 31(Suppl 1):39-41
44. Austin P, Jakobiec FA, Iwamoto T: Elastodysplasia and elastodystrophy as the pathologic bases of ocular pterygia and pinguecula. Ophthalmology 1983, 90:96-109 (Pubitemid 13175782)
45. D'Alena P, Wood IS: Labrador keratopathy: a microscopic study. Am J Ophthalmol 1972, 74:430-435
46. Johnson GJ, Overall M: Histology of spheroidal degeneration of the cornea in Labrador. Br J Ophthalmol 1978, 62:53-61 (Pubitemid 8292955)
47. Menegay M, Lee D, Tabbara KF, Cafaro TA, Urrets-Zavalia JA, Serra HM, Bhattacharya SK: Proteomic analysis of climatic keratopathy droplets. Invest Ophthalmol Vis Sci 2008, 49:2829-2837
48. Ansari MW, Rahi AH, Shukla BR: Pseudoelastic nature of pterygium, Br J Ophthalmol 1970, 54:473-476
49. Wang IJ, Hu FR, Chen PJ, Lin CT: Mechanism of abnormal elastin gene expression in the pinguecular part of pterygia. Am J Pathol 2000, 157:1269-1276
50. Coroneo MT: Albedo concentration in the anterior eye: a phenomenon that locates some solar diseases. Ophthalmic Surg 1990, 21:60-66
51. Dushku N, Reid TW: Immunohistochemical evidence that human pterygia originate from an invasion of vimentin-expressing altered limbal epithelial basal cells. Curr Eye Res 1994, 13:473-481 (Pubitemid 24215983)
52. Duke-Elder S, Wybar KC (Ed): The Anatomy of the Visual System. System of Ophthalmology 2. London: Kimpton, 1961, p 557
53. Grossniklaus HE, Green WR, Luckenbach M, Chan CC: Conjunctival lesions in adults: a clinical and histopathologic review. Cornea 1987, 6:78-116 (Pubitemid 17127430)
54. Basti S, Macsai MS: Ocular surface squamous neoplasia: a review. Cornea 2003, 22:687-704 (Pubitemid 37175152)
55. Lee GA, Hirst LW: Ocular surface squamous neoplasia. Surv Ophthalmol 1995, 39:429-450
56. Pola EC, Masanganise R, Rusakaniko S: The trend of ocular surface squamous neoplasia among ocular surface tumour biopsies submitted for histology from Sekuru Kaguvi Eye Unit, Harare between 1996 and 2000. Cent Afr J Med 2003, 49:1-4
57. Nkomazana O, Tshitswana D: Ocular complications of HIV infection in sub-Sahara Africa. Curr HIV/AIDS Rep 2008, 5:120-125
58. Ng J, Coroneo MT, Wakefield D, Di Girolamo N: Ultraviolet radiation and the role of matrix metalloproteinases in the pathogenesis of ocular surface squamous neoplasia. Invest Ophthalmol Vis Sci 2008, 49:5295-5306
59. Oren M: Decision making by p53: life, death and cancer. Cell Death Differ 2003, 10:431-442
60. Dushku N, Reid TW: P53 expression in altered limbal basal cells of pingueculae, pterygia, and limbal tumors. Curr Eye Res 1997, 16:1179-1192 (Pubitemid 27515671)
61. Dushku N, Hatcher SL, Albert DM, Reid TW: p53 expression and relation to human papillomavirus infection in pingueculae, pterygia, and limbal tumors. Arch Ophthalmol 1999, 117:1593-1599 (Pubitemid 30003291)
62. Tan DT, Lim AS, Goh HS, Smith DR: Abnormal expression of the p53 tumor suppressor gene in the conjunctiva of patients with pterygium. Am J Ophthalmol 1997, 123:404-405 (Pubitemid 27123052)
63. Guthoff R, Marx A, Stroebel P: No evidence for a pathogenic role of human papillomavirus infection in ocular surface squamous neoplasia in Germany. Curr Eye Res 2009, 34:666-671
64. Ateenyi-Agaba C, Dai M, Le Calvez F, Katongole-Mbidde E, Smet A, Tommasino M, Franceschi S, Hainaut P, Weiderpass E: TP53 mutations in squamous-cell carcinomas of the conjunctiva: evidence for UV-induced mutagenesis. Mutagenesis 2004, 19:399-401 (Pubitemid 39405977)
65. Schneider BG, John-Aryankalayil M, Rowsey JJ, Dushku N, Reid TW: Accumulation of p53 protein in pterygia is not accompanied by TP53 gene mutation. Exp Eye Res 2006, 82:91-98 (Pubitemid 43065489)
66. Shields JA, Shields CL, Mashayekhi A, Marr BP, Benavides R, Thangappan A, Phan L, Eagle RC Jr: Primary acquired melanosis of the conjunctiva: risks for progression to melanoma in 311 eyes. The 2006 Lorenz E. Zimmerman lecture. Ophthalmology 2008, 115:511-519.e2
67. Shields CL, Demirci H, Karatza E, Shields JA: Clinical survey of 1643 melanocytic and nonmelanocytic conjunctival tumors. Ophthalmology 2004, 111:1747-1754 (Pubitemid 39179692)
68. Sugiura M, Colby KA, Mihm MC Jr, Zembowicz A: Low-risk and high-risk histologic features in conjunctival primary acquired melanosis with atypia: clinicopathologic analysis of 29 cases. Am J Surg Pathol 2007, 31:185-192 (Pubitemid 46175018)
69. Folberg R, McLean IW, Zimmerman LE: Primary acquired melanosis of the conjunctiva. Hum Pathol 1985, 16:129-135 (Pubitemid 15136923)
70. Bongiorno MR, Lodato G, Affronti A, Aragona F, Arico M: Amelanotic conjunctival melanoma. Cutis 2006, 77:377-381 (Pubitemid 44032551)
71. Tatla T, Hungerford J, Plowman N, Ghufoor K, Keene M: Conjunctival melanoma: the role of conservative surgery and radiotherapy in regional metastatic disease. Laryngoscope 2005, 115:817-822 (Pubitemid 40604686)
72. Sharara NA, Alexander RA, Luthert PJ, Hungerford JL, Cree IA: Differential immunoreactivity of melanocytic lesions of the conjunctiva. Histopathology 2001, 39:426-431 (Pubitemid 32990096)
73. Jakobiec FA, Bhat P, Colby KA: Immunohistochemical studies of conjunctival nevi and melanomas. Arch Ophthalmol 2010, 128:174-183
74. Furusato E, Hidayat AA, Man YG, Auerbach A, Furusato B, Rushing EJ: WT1 and Bcl2 expression in melanocytic lesions of the conjunctiva: an immunohistochemical study of 123 cases. Arch Ophthalmol 2009, 127:964-969
75. Tabin G, Levin S, Snibson G, Loughnan M, Taylor H: Late recurrences and the necessity for long-term follow-up in corneal and conjunctival intraepithelial neoplasia. Ophthalmology 1997, 104:485-492 (Pubitemid 27120305)
76. Kim JW, Abramson DH: Topical treatment options for conjunctival neoplasms. Clin Ophthalmol 2008, 2:503-515
77. Schechter BA, Koreishi AF, Karp CL, Feuer W: Long-term follow-up of conjunctival and corneal intraepithelial neoplasia treated with topical interferon alfa-2b. Ophthalmology 2008, 115:1291-1296
78. Skippen B, Tsang HH, Assaad NN, Coroneo MT: Rapid response of refractory ocular surface dysplasia to combination treatment with topical all-trans retinoic acid and interferon alfa-2b. Arch Ophthalmol 2010, 128:1368-1369